Steerable vs Conventional FANS for <2cm Lower Pole Stone Treatment: SCULPT Trial

NCT ID: NCT06898216

Last Updated: 2025-03-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

400 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-03-16

Study Completion Date

2026-03-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This multicenter, randomized, controlled superiority trial (the SCULPT trial) aims to compare the efficacy and safety of a novel steerable flexible and navigable suction ureteral access sheath (FANS) versus the conventional FANS in the treatment of lower pole renal stones ≤2 cm. Lower pole stones are particularly challenging due to the narrow infundibular-pelvic anatomy that limits the maneuverability of standard FANS. The steerable FANS incorporates an active deflection mechanism that allows for independent control, potentially improving the success rate of accessing the lower pole calyx, performing laser lithotripsy, and aspirating stone fragments without additional adjuncts.

A total of 400 patients from 20 high-volume urological centers in China (approximately 20 patients per center) will be randomized in a 1:1 ratio to receive either steerable FANS or conventional FANS during flexible ureteroscopy. Primary outcome measures include the success rate of FANS navigation into the lower pole calyx as evidenced by direct stone visualization, effective laser lithotripsy, and successful stone aspiration. Secondary outcomes will assess immediate and 1-month stone-free rates, operative time, complication rates, instrument durability, and improvements in quality of life. This study is expected to provide critical evidence to guide clinical decision-making and potentially improve treatment efficiency for challenging lower pole renal stones.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This trial is designed in response to the current challenges faced in the management of lower pole renal stones using flexible ureteroscopy, particularly when using conventional FANS. The narrow calyceal angles and complex lower pole anatomy can impede the passage of the access sheath, thereby limiting the efficiency of stone fragmentation and clearance. The innovative steerable FANS overcomes these limitations by offering an independent, active deflection mechanism that facilitates a greater range of movement, thus optimizing the access to lower pole calyces.

Background and Objectives Lower pole stones are notoriously difficult to treat due to their anatomical position and the limited maneuverability of conventional ureteral access sheaths. The new steerable FANS, with its deflection lever at the distal handle, allows for active, independent adjustment under endoscopic guidance, which may result in a higher success rate of reaching the lower pole and more efficient stone clearance. The primary objective of this trial is to compare the success rate of FANS navigation into the lower pole renal calyx between the steerable and conventional devices. Secondary objectives include the evaluation of immediate (within 24 hours) and 1-month stone-free rates, operative time, length of hospital stay, usage of auxiliary devices (e.g., stone baskets), instrument damage rates, complication rates (graded by the Clavien-Dindo system), and the impact on patient quality of life (assessed via the Wisconsin Stone QoL questionnaire).

Study Design and Methods

Trial Type:

This is a multicenter, prospective, single-blind, superiority, randomized controlled trial.

Study Setting and Participants:

The study will be conducted at 20 high-volume urological centers across China, with each center recruiting approximately 20 patients. Eligible participants are adults aged 18-75 years, diagnosed with a single lower pole renal stone ≤2 cm (confirmed by CT) and who meet all inclusion and exclusion criteria.

Randomization and Group Allocation:

A centralized, stratified randomization process (1:1 ratio) will allocate patients to either the steerable FANS or conventional FANS group. Random sequences will be generated electronically using permuted blocks within each center to maintain allocation concealment.

Interventions:

All patients will undergo flexible ureteroscopy under general anesthesia with standardized use of 7.5 Fr digital flexible ureteroscopes. Preoperative imaging (contrast-enhanced CT urography) will assess stone size, location, and anatomical parameters. Depending on ureteral diameter, an appropriate FANS (either 11/13 Fr or a smaller version) will be selected. Laser lithotripsy will be performed using a 200 µm laser fiber (energy settings ≤30 W) alongside continuous negative-pressure suction to aspirate stone fragments. If the sheath cannot be navigated into the lower pole due to anatomical constraints, an adjunct stone basket may be employed.

Outcome Measures:

Primary Outcome:

The success rate of FANS navigation into the lower pole calyx, defined as the sheath reaching the calyx, performing effective laser lithotripsy, and aspirating stone fragments without additional adjuncts.

Secondary Outcomes:

These include the immediate (24-hour) and final (1-month) stone-free rates (defined as no residual stone or fragments \>2 mm on CT), operative time, duration of hospital stay, intraoperative usage of adjunct devices, damage rates of the ureteroscope and FANS, complications within one month (graded by Clavien-Dindo), and quality of life improvements as measured by the Wisconsin Stone QoL questionnaire.

Follow-up and Data Collection:

Patients will undergo a low-dose CT scan within 24 hours postoperatively to assess the immediate stone-free status, with a follow-up CT at 1 month for final assessment. Clinical data, including operative details and follow-up results, will be recorded in standardized case report forms (CRFs) at each center. This will ensure consistency and completeness of data across the multicenter trial.

Sample Size and Statistical Analysis:

Based on preliminary data showing a 60% success rate with conventional FANS and an anticipated 80% with the steerable FANS, with a superiority margin of 6%, a total of 400 participants (200 per group) has been calculated to achieve 80% power at a one-sided α of 2.5%, accounting for potential dropouts. Statistical analyses will be conducted using SPSS software, with continuous variables analyzed via t-tests or Mann-Whitney U tests (depending on data distribution) and categorical variables assessed using chi-square or Fisher's exact tests. Multivariate analyses will be performed where necessary, and results will be presented with 95% confidence intervals.

Quality Control and Safety Monitoring:

All participating centers will undergo standardized training to ensure uniformity in surgical procedures and data collection. Monthly monitoring visits will verify protocol adherence and data integrity. Any adverse events will be meticulously recorded and reported promptly to the Ethics Committee, with regular cumulative safety reviews performed by the principal investigator.

Significance and Expected Outcomes This trial is the first head-to-head comparison of steerable versus conventional FANS in the management of lower pole renal stones. If the steerable FANS demonstrates superiority in navigating the lower pole and enhancing stone clearance efficiency, it could transform the current endourological approach to challenging renal calculi. In addition, the comprehensive evaluation of instrument durability and complication profiles will aid in economic assessments and inform patient counseling regarding procedural risks and benefits. Ultimately, the findings of this study are expected to contribute robust evidence toward optimizing clinical strategies, improving patient outcomes, and potentially expanding the indications for flexible ureteroscopy in complex renal stone management.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Kidney Stones

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Steerable FANS Arm

Participants assigned to this arm will undergo flexible ureteroscopy using the novel steerable flexible and navigable suction ureteral access sheath (FANS). This device incorporates an active deflection mechanism that allows for independent adjustment to optimize navigation into the lower pole calyx. The procedure is performed under general anesthesia with a standardized 7.5 Fr digital flexible ureteroscope, using a 200 µm holmium laser (energy settings ≤30 W) for lithotripsy, and continuous negative-pressure suction for stone fragment aspiration. Adjunct devices (e.g., stone baskets) may be utilized if necessary.

Group Type EXPERIMENTAL

Steerable FANS

Intervention Type DEVICE

This device is designed for flexible ureteroscopy procedures in patients with lower pole renal stones ≤2 cm. It features an active deflection mechanism that enables independent adjustment to enhance access into the lower pole calyx. The description focuses solely on the device and does not include procedural details already provided in the arm description.

Conventional FANS Arm

Participants assigned to this arm will receive flexible ureteroscopy using the conventional flexible and navigable suction ureteral access sheath (FANS), which relies on passive deflection provided by the ureteroscope for navigation into the lower pole calyx. The procedure is conducted under general anesthesia with a 7.5 Fr digital flexible ureteroscope, employing a 200 µm holmium laser (energy settings ≤30 W) for lithotripsy and continuous negative-pressure suction for fragment removal. Adjunctive retrieval tools (e.g., stone baskets) may be used as required.

Group Type ACTIVE_COMPARATOR

Conventional FANS

Intervention Type DEVICE

This device is intended for use in flexible ureteroscopy for lower pole renal stone management. It relies on passive deflection provided by the flexible ureteroscope for navigation into the lower pole calyx. The description is limited to the device characteristics without duplicating procedural details from the arm description.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Steerable FANS

This device is designed for flexible ureteroscopy procedures in patients with lower pole renal stones ≤2 cm. It features an active deflection mechanism that enables independent adjustment to enhance access into the lower pole calyx. The description focuses solely on the device and does not include procedural details already provided in the arm description.

Intervention Type DEVICE

Conventional FANS

This device is intended for use in flexible ureteroscopy for lower pole renal stone management. It relies on passive deflection provided by the flexible ureteroscope for navigation into the lower pole calyx. The description is limited to the device characteristics without duplicating procedural details from the arm description.

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Steerable Flexible and Navigable Suction Ureteral Access Sheath Conventional Flexible and Navigable Suction Ureteral Access Sheath

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adults aged 18-75 years
* Diagnosed with a single lower pole renal stone ≤2 cm by CT
* American Society of Anesthesiology (ASA) score of 1-3
* Ability to provide written informed consent
* Willingness and ability to comply with trial procedures and follow-up

Exclusion Criteria

* Patients with urinary tract anatomical abnormalities (e.g., horseshoe kidney, ileal conduit)
* Untreated urinary tract infection
* Presence of multiple stones or stones located outside the lower pole
* Absolute contraindications to flexible ureteroscopy
* Inability to understand or complete trial documentation
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

the third Medical Center, PLA General Hospital

UNKNOWN

Sponsor Role collaborator

First Affiliated Hospital of Chongqing Medical University

OTHER

Sponsor Role collaborator

Peking University People's Hospital

OTHER

Sponsor Role collaborator

The Second Affiliated Hospital of Kunming Medical University

OTHER

Sponsor Role collaborator

The Fifth Affiliated Hospital, Sun Yat-sen University

UNKNOWN

Sponsor Role collaborator

Henan Provincial People's Hospital

OTHER

Sponsor Role collaborator

Nanfang Hospital, Southern Medical University

OTHER

Sponsor Role collaborator

Wuhan Hospital of Traditional Chinese Medicine

OTHER

Sponsor Role collaborator

Dongguan People's Hospital

OTHER_GOV

Sponsor Role collaborator

Changzhou No.2 People's Hospital

OTHER

Sponsor Role collaborator

Dongguan Tungwah Hospital

OTHER

Sponsor Role collaborator

Panzhihua Central Hospital

OTHER

Sponsor Role collaborator

Yan'an Hospital of Kunming City

UNKNOWN

Sponsor Role collaborator

NO.1 People's Hospital of Dali City

UNKNOWN

Sponsor Role collaborator

Huadu District People's Hospital of Guangzhou

OTHER

Sponsor Role collaborator

Jiangmen Central Hospital

OTHER

Sponsor Role collaborator

Shaoyang Central Hospital

UNKNOWN

Sponsor Role collaborator

Guangzhou Medical University Affiliated Qingyuan Hospital

UNKNOWN

Sponsor Role collaborator

Dongguan Kanghua Hospital

OTHER

Sponsor Role collaborator

The First Affiliated Hospital of Guangzhou Medical University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Guohua Zeng

Vice president

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Guohua Zeng, M.D.

Role: PRINCIPAL_INVESTIGATOR

The First Affiliated Hospital of Guangzhou Medical University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Urology, The First Affiliated Hospital of Guangzhou Medical University

Guangzhou, Guangdong, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Guohua Zeng, M.D.

Role: CONTACT

13622754991

Steffi Yuen, M.D.

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Guohua Zeng, M.D.

Role: primary

+8613802916676

Wei Zhu, M.D.

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ES-2025-033

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Management of Medium Sized Renal Stones
NCT06720311 NOT_YET_RECRUITING NA